ARMIS BIOPHARMA, INC.

Fort Collins, CO · Defense · Private

Veriox®, a proprietary chemical formulation for rapid skin decontamination of nerve agents and chemical warfare agents

Claim this profile

Follows are private to you and power your alerts

Updated · armisbiopharma.com

Sector
Defense
Headquarters
Fort Collins, CO
Latest Form D
$1M, Jul 2025
Total capital
$20.9M
Federal grants
$2.9M
5 awards · 2020–2023
Rank in peer group#398 of 1418
Private capital raised
$13.2M
8 Form D · last Jul 2025
16 months since last filing
Federal contracts
$4.8M
1 award · Defense
Rank in Defense#541 of 1442
Granted patents
8
18 pending · first 2021
Rank in peer group#119 of 1418

Capital timeline

201420162018202020222024FEDERAL ↑EQUITY ↓Cumulative $34.9M$423K$271K$1.4M$829K$30K$4.8M1st Form D$2.5M6th Form D$1.8M7th Form D$5.3M8th Form D$1M
201420162018202020222024FEDERAL ↑EQUITY ↓Cumulative $34.9M$423K$1.4M$4.8M7th Form D$5.3M

Latest events

  • Private capital raisedForm D · SEC · 8th filing$1M
  • Federal contractDefense · Research And Development To Support Veriox Decontamination Kit To Treat Chemical Weapon Agents.$4.8M
  • Federal grantHealth and Human S · Phase II · Development of a novel product for skin decontamination after exposure to chemical warfare agents$30K
  • Federal grantHealth and Human S · Phase II · Development of a novel product for skin decontamination after exposure to chemical warfare agents$829K
  • Federal grantHealth and Human S · Phase II · Development of a novel product for skin decontamination after exposure to chemical warfare agents$1.4M
  • Private capital raisedForm D · SEC · 7th filing$5.3M
  • Federal grantHealth and Human S · Phase II · Development of a novel product for skin decontamination after exposure to chemical warfare agents$271K
  • Private capital raisedForm D · SEC · 6th filing$1.8M
  • Private capital raisedForm D · SEC · 5th filing$125K
  • Offering registeredForm D · SEC · 4th filing$14M
  • Private capital raisedForm D · SEC · 3rd filing$758K
  • Private capital raisedForm D · SEC · 2nd filing$1.7M
  • Private capital raisedForm D · SEC · 1st filing$2.5M
Show 1 earlier federal award
  • Federal grantHealth and Human S · Phase II · Development of a novel product for skin decontamination after exposure to chemical warfare agents$423K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1418 peers

Line = median

Defense · Molecule

  • Federal grants#398 · top 28%
  • Granted patents#119 · top 8%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Ed NeasResearcherDirectorLinked by 1 patent
  • Alan RuudDirectorNamed in SEC Form D filings
  • Alan SmithDirectorNamed in SEC Form D filings
  • Alan Smith, Ph.D.DirectorNamed in SEC Form D filings
  • Christopher RuddDirectorNamed in SEC Form D filings
  • Christopher RuudExecutive Officer, DirectorNamed in SEC Form D filings
Show all 18 people
  • Dennis TemplarExecutive Officer, DirectorNamed in SEC Form D filings
  • Ed Neas, Ph.D.DirectorNamed in SEC Form D filings
  • Michael LitwackDirectorNamed in SEC Form D filings
  • Michael VossExecutive Officer, DirectorNamed in SEC Form D filings
  • Robert KaliExecutive OfficerNamed in SEC Form D filings
  • Stephen CoderDirectorNamed in SEC Form D filings
  • Steve CoderExecutive Officer, DirectorNamed in SEC Form D filings
  • Ted ZiemannExecutive Officer, DirectorNamed in SEC Form D filings
  • Theodore ZiemannDirectorNamed in SEC Form D filings
  • William NelsonDirectorNamed in SEC Form D filings
  • William Nelson, MD, Ph.D.DirectorNamed in SEC Form D filings
  • William Nelson, MD. Ph.D.DirectorNamed in SEC Form D filings

What it has protected

USPTO · 8 granted of 26
Show all 26 patent records
  • ADVANCED FIBER SENSORS INCSimilar federal contract value in Defense · $4.8M in contracts
  • SKY SIGHT TECHNOLOGIES, LLCSimilar federal contract value in Defense · $4.8M in contracts
  • EVERACTIVE, INC.Similar federal contract value in Defense · $4.8M in contracts
  • VESPERIX CORPSimilar federal contract value in Defense · $4.7M in contracts
  • MICROSURGEONBOT INCSimilar federal contract value in Defense · $4.7M in contracts
  • Elemance, LLCSimilar federal contract value in Defense · $4.7M in contracts

Regulatory activity · Defense

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .